Seligmann JF, Morton D, Elliott F, Handley K, et al. Corrigendum to "Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population": [Ann Oncol 36 (2025) 520-528]. Ann Oncol 2025 Oct 9:S0923-7534(25)04703-9. doi: 10.1016/j.annonc.2025.
PMID: 41073245